Porous Baseplate in Total Knee Replacement

Sponsor
Canadian Radiostereometric Analysis Network (Other)
Overall Status
Recruiting
CT.gov ID
NCT05226689
Collaborator
(none)
30
2
1
31.7
15
0.5

Study Details

Study Description

Brief Summary

This is a multi-centre single cohort trial of patients undergoing cruciate-retaining total knee arthroplasty with the Advance Porous fixed bearing tibial baseplate and compatible femoral, patellar, and bearing components.

Condition or Disease Intervention/Treatment Phase
  • Device: POROUS TIBIA BASEPLATE W/ JRNY LOCK
N/A

Detailed Description

All patients will undergo post-operative model-based RSA to identify migration of the tibial baseplate with respect to the bone as well as migration of the patellar and femoral components with respect to the bone during the first 2 post-operative years. Patient health and functional outcomes will be recorded at pre- and post-operative intervals for all patients. Peri-operative adverse events and other clinical complications will be captured as encountered.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective, Multicenter, RSA Study of the Porous Tibia Baseplate W/Jrny Lock
Actual Study Start Date :
Apr 11, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: POROUS TIBIA BASEPLATE W/ JRNY LOCK

Fixed-bearing POROUS TIBIA BASEPLATE W/ JRNY LOCK and a Legion cruciate-retaining High-Flex or Deep-dish XLPE tibial insert.

Device: POROUS TIBIA BASEPLATE W/ JRNY LOCK
Fixed-bearing POROUS TIBIA BASEPLATE W/ JRNY LOCK and a Legion cruciate-retaining High-Flex or Deep-dish XLPE tibial insert

Outcome Measures

Primary Outcome Measures

  1. Change between 6 months and 1-year post-operative - tibial baseplate stability [6 Months and 1 Year]

    Maximum total point motion (MTPM) migration of the POROUS TIBIA BASEPLATE W/ JRNY LOCK between 6 months and 1 year post-operative (mm)

Secondary Outcome Measures

  1. Change between 1- and 2-years post-operative - tibial baseplate stability [1 Year and 2 Years]

    Maximum total point motion (MTPM) migration of the POROUS TIBIA BASEPLATE W/ JRNY LOCK between 1 year and 2 years post-operative (mm)

  2. Total MTPM migration of the baseplate at 1 year [1 Year]

    Assessment of the stability of the tibial baseplate (mm)

  3. Establish the post-operative migration pattern of the patellar and femoral components [6 Weeks and 6 Months]

    Assessment of the migration pattern (mm)

  4. What is the magnitude of baseplate displacement that results from patient weight-bearing (single leg stance) versus non-weight-bearing at 1-year post-operation? [1 Year]

    Assessment of the baseplate displacement differences between standing and supine RSA (mm)

  5. European Quality of Life (EQ-5D-5L) [Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years]

    EQ5D consists of 5 subscales; Mobility, Self-care, Usual activities, Pain/Discomfort and Anxiety / depression. A health state score is obtained based on the responses from 1-5 in each subscale, from which a single index value is calculated representing patients' overall health state. EQ5D includes a so called EQ VAS score which is the patients' self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled "the best health you can imagine" and "the worst health you can imagine".

  6. Patient-reported Outcome: Oxford Knee Score [Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years]

    The Oxford Knee Score (OKS) is a patient self-administered 12-item questionnaire with each question having a Likaert-like response option. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance. The OKS measures pain and general activities of daily living.

  7. Forgotten Joint Score (FJS) [Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years]

    The FJS total score range is 0-100, higher scores indicating the patient is able to forget the joint daily or lower degree of joint awareness.

  8. Knee Injury and Osteoarthritis Outcomes Score (KOOS JR.) [Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years]

    The KOOS JR. was a participant completed questionnaire that consists of 7 questions from 3 subscales: stiffness (1 question), pain (4 questions), and function in daily living (2 questions). Standardized answer options are given (5 Likert boxes) and each question was assigned a score from none (0) to extreme (4).

  9. University of California at Los Angeles (UCLA) Activity Level scale [Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.

  10. Pain VAS [Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable)

  11. Satisfaction VAS [Preoperative, 6 Months, 1 Year and 2 Years]

    Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied)

  12. Patient complications [6 Weeks, 6 Months, 1 Year and 2 Years]

    Evaluate the type and frequency of the complications/adverse events.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Symptomatic osteoarthritis of the knee indicating primary unilateral total knee arthroplasty

  • Sufficient ligamentous function to warrant retention of the posterior cruciate ligament

  • Aged 21 years or older

  • Patients willing and able to comply with follow-up requirements and self-evaluations

  • Ability to give informed consent

Exclusion Criteria:
  • Active or prior infection

  • Medical condition precluding major surgery

  • Known medical condition limiting patient life expectancy to < 2 years

  • Expected to receive contralateral TKA within 1 year

  • Inflammatory arthropathy

  • Prior patellectomy

  • PCL deficiency

  • Major (>25 degree) coronal plane deformity

  • Bilateral coronal plane deformity requiring simultaneous bilateral TKA

  • Bone defects requiring augments, cones and/or stemmed implants

  • Body Mass Index greater than 40

Contacts and Locations

Locations

Site City State Country Postal Code
1 Concordia Hospital Winnipeg Manitoba Canada R2K 3S8
2 London Health Sciences Centre London Ontario Canada N6A 5W9

Sponsors and Collaborators

  • Canadian Radiostereometric Analysis Network

Investigators

  • Principal Investigator: Douglas Naudie, MD, London Health Sciences Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Canadian Radiostereometric Analysis Network
ClinicalTrials.gov Identifier:
NCT05226689
Other Study ID Numbers:
  • B2021:110
First Posted:
Feb 7, 2022
Last Update Posted:
May 20, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 20, 2022